The efficacy and safety of novel antidiabetic agents in polycystic ovary syndrome: a network meta-analysis - PubMed
5 hours ago
- #PCOS
- #antidiabetic agents
- #network meta-analysis
- The study evaluates the efficacy and safety of novel antidiabetic agents in treating polycystic ovary syndrome (PCOS) through a network meta-analysis.
- Key antidiabetic agents discussed include DPP-4 inhibitors, GLP-1 receptor agonists, Metformin, and SGLT-2 inhibitors.
- The research highlights the importance of addressing insulin resistance and metabolic issues in PCOS management.
- References cited provide context on PCOS's definition, diagnosis, treatment, and its long-term metabolic consequences.
- The authors declare no competing interests, emphasizing the impartiality of the study.